Based on the results of recent testing a U.S. Food and Drug Administration (FDA) expert panel has recommended that febuxostat be approved. This would make febuxostat, to be marketed as Uloric, the first gout drug to be approved in over 40 years. [...]
|
|||||||
|
The Japanese pharmaceutical, Takeda, has been testing a new drug for use in treating gout. They had applied for approval by the U.S. Food and Drug Administration (FDA) in 2004, but the FDA had requested more data as a result of concerns about a possible increase in heart attack risk. The drug is known [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
